Ivan I. Sergeev

Ivan I. Sergeev

Auto-generated profile, based on publicly available information

Ivan I. Sergeev

Chuvash State University named after I.N. Ulyanov

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 September 2021 in Acta medica Eurasica
Verified
Journal Article
Closed access
TDTamara G. Denisova
Tamara G. Denisova
ASAdelina I. Sergeeva
Adelina I. Sergeeva
AGAlexandra S. Grigorieva
Alexandra S. Grigorieva
EREnje E. Rechapova
Enje E. Rechapova
ISIvan I. Sergeev
Ivan I. Sergeev
EDElena A. Denisova
Elena A. Denisova
According to the WHO statement dated March 11, 2020, the coronavirus infection SARS-CoV-2 has reached the scale of a pandemic and is currently a world health problem. A special group of the population that requires increased attention is pregnant women due to the fact that pneumonia occupies the third place in the structure of indirect causes of maternal mortality. Pregnant women whose immune system has changed appeared to be at an increased risk of infection. Pregnancy is a risk factor for the development of a more severe course of acute respiratory viral diseases and influenza. To date, the issue of intrauterine transmission of coronavirus disease remains completely unexplored, which causes fear among pregnant women for the future generation. Addition of a new coronavirus infection SARS-CoV-2 has a negative impact on pregnancy, childbirth and the postpartum period, the health of newborns, especially in patients with a burdened obstetric history. Pregnancy itself and childbirth do not affect the course of COVID-19, but the infection addition can complicate the course of gestation, causing respiratory distress syndrome, premature birth and spontaneous miscarriages, congenital pneumonia and antenatal death of newborns born from covid-positive mothers. The literature published from December 1, 2019 to July 30, 2021 was searched in several databases, including PubMed, Web of Science, Google Scholar and the WHO COVID-19 database, of which 52 articles were selected for detailed consideration. The relevant literature was searched to understand the issues of infection transmission to newborns from infected mothers and the clinical manifestations of the disease in the former. As a result, it was found that newborns can become infected with SARS-Cov-2 in close contact with infected patients or asymptomatic virus carriers. However, based on the data of modern literature, it is impossible to unequivocally answer the questions posed, more facts are needed to solve the problem. The practical significance of the work is that the results of the study should be used for further studying the consequences of COVID-19 for the health of newborn children.

13 May 2024
Verified
Journal Article
Closed access
AFA.V. Filonenko
A.V. Filonenko
ASA.I. Sergeeva
A.I. Sergeeva
VFV.A. Filonenko
V.A. Filonenko
AGA.V. Golenkov
A.V. Golenkov
ISI.I. Sergeev
I.I. Sergeev

12 August 2024 in Russian Journal of Pediatric Hematology and Oncology
Verified
Journal Article
Open access
PDF file
ISI. I. Sergeev
I. I. Sergeev
KBK. D. Burtsev
K. D. Burtsev
NSN. S. Smetanina
N. S. Smetanina
The purpose of this review is to update information about the epidemiology, clinical-pathogenetic and genetic characteristics, and therapeutic approach to familial inherited erythrocytosis (FIE) in children in the Chuvash Republic.This review presents updated data indicating that the variant of congenital polycythemia with the VHLR200W (598C>T) mutation in the Chuvash Republic does not have the expected association with tumor predisposition syndrome induced by VHL and does not lead to an increased frequency of their occurrence. Thrombosis largely explains the morbidity and mortality from congenital erythrocytosis, but patients with the Chuvash mutation show a reduced body mass index, systolic blood pressure levels, glucose and HbA1c levels, and leukocyte and platelet counts compared to control groups. A higher hematocrit level is not an independent predictor of thrombotic risk in children and adults. Moreover, prospective randomized studies have demonstrated that phlebotomy, performed to reduce hematocrit levels, is associated with a higher thrombotic risk.